Search for: "Pfizer Ireland Pharmaceuticals" Results 1 - 20 of 36
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Mar 2024, 7:24 pm by Kurt R. Karst
§ 1.750, applicant is required to submit the following to the Office: Evidence that Opko Biologics Ltd. is expressly authorized to rely upon the regulatory review activities by Pfizer Ireland Pharmaceuticals (Pfizer), the marketing applicant before the Food and Drug Administration to support the application for patent term extension of U.S. [read post]
3 Feb 2021, 1:04 am by Florian Mueller
The recent deal between Pfizer partner BioNTech and Sanofi (which invested in BioNTech two years ago) shows that solutions can be worked out at the negotiating table. [read post]
4 Feb 2019, 4:33 am by Oswin Ridderbusch
Thus, it should be borne in mind that the paediatric extension is ancillary to the SPC itself, and thus does not constitute a distinct IP right but merely alters the term of an SPC, as recently acknowledged by the CJEU in Pfizer Ireland (C-681/16). [read post]
7 Aug 2018, 10:05 pm by Mark Summerfield
  Prior to this change, advice provided by foreign practitioners was not protected by patent attorney privilege (Eli Lilly & Company v Pfizer Ireland Pharmaceuticals (No 2) [2004] FCA 850: ‘The language of s 200(2) is clear. [read post]
30 Dec 2017, 7:44 am
On November 23rd, 2015, pharmaceutical giant, Pfizer, officially announced that it had reached an agreement with its competitor, Allergan, to merge the two companies in a deal that would have created the largest pharmaceutical company in the world. [read post]
9 Dec 2017, 9:46 pm by Mark Summerfield
  I therefore indicated that I would not be at all surprised to see the decision appealed.Pfizer did indeed appeal, and a Full Bench of the Federal Court of Australia has now handed down its decision, with three judges unanimous in overturning Justice Burley’s decision and granting Pfizer preliminary discovery: Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd [2017] FCAFC 193.The key to Pfizer’s successful appeal lies in the… [read post]
11 Oct 2017, 8:17 am
The two brands had been sold alongside each other in the UK and Ireland for some time, without apparent issue. [read post]
26 Mar 2017, 1:49 am by Mark Summerfield
  Unfortunately for Pfizer, Justice Stephen Burley has denied its application for discovery, ruling its evidence insufficient to establish a ‘reasonable belief’, as opposed to a ‘mere suspicion’, that SBA is infringing its patents relating to a process for producing etanercept: Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd [2017] FCA 285. [read post]
5 Aug 2016, 4:00 am by LindaMBeale
  The business groups claim that the regulations are making business harder for big companies to carry out transactions, referencing the proposed merger between U.S. drugmaker Pfizer and Ireland pharmaceutical company Allergan (both members of the Chamber of Commerce). [read post]
5 Aug 2016, 4:00 am by LindaMBeale
  The business groups claim that the regulations are making business harder for big companies to carry out transactions, referencing the proposed merger between U.S. drugmaker Pfizer and Ireland pharmaceutical company Allergan (both members of the Chamber of Commerce). [read post]
7 Apr 2016, 9:51 pm by RegBlog
U.S. pharmaceutical giant Pfizer called off a contemplated $150 billion merger with Ireland-based Allergan in response to the Internal Revenue Service (IRS) and U.S. [read post]
16 Jul 2015, 4:00 am by Martin Kratz
Pfizer Ireland Pharmaceuticals 2006 FC 1465, where Lilly sought to impeach Pfizer’s patent on the Cialis drug and sought to get access to communications between the inventors and the U.K. [read post]
2 Jul 2015, 4:00 am by Alan Macek
Pfizer Ireland Pharmaceuticals, 2006 FC 1465). [read post]
19 Sep 2014, 5:50 pm
Steven gave an example of the Canadian Federal Court case of Lilly Icos v Pfizer Ireland Pharmaceuticals (2006) FC 1465, where communications between Pfizer and a UK patent attorney was held not to be privileged. [read post]
13 Apr 2014, 8:59 am by Barry Sookman
For example, the US Congress,[2] the European Union[3] and its member states including the UK[4] and Ireland,[5] Australia[6] and others have been re-examining their copyright laws in light of the challenges posed by digital technologies. [read post]
7 Nov 2013, 4:57 pm by Kelly Phillips Erb
In case you’re having a hard time figuring out who they’re fingering, I’ll help you out: Apple, Google, Microsoft, Pfizer and Dell. [read post]
17 Jun 2012, 3:52 pm by Stephen Jenei
Betsy led the team that developed Pfizer’s U.S. [read post]
2 Nov 2011, 2:00 am by Marie Louise
Research & Diagnostic Systems (Pharma Patents) US: Roundup Ready® Soybeans: Patent exhaustion in self-replicating biotechnologies (IP Osgoode) US: FDA continues efforts to expand power over intrastate commerce (FDA Law Blog) US: Defendants’ persistence in pursuing “baseless inequitable conduct claim” justified award of attorneys’ fees to plaintiff: Pfizer et. al v. [read post]
24 Oct 2011, 1:39 pm by FDABlog HPM
  The court’s August 16, 2011 judgment stated: IT IS ORDERED AND ADJUDGED that Teva Pharmaceuticals USA, Inc.'s Motion to Dismiss for Lack of Standing is GRANTED IN PART, and Pfizer Ireland Pharmaceuticals Co. is DISMISSED from this litigation; that judgment is entered for Pfizer Inc. and Pfizer Ltd. on the Amended Complaint and Amended Counterclaim, in accordance with the Court’s Opinion and Final Order which found that… [read post]
29 Aug 2011, 7:56 am by Sonya Hubbard
That is the case for Anthony Bruno, the Executive Vice President, Corporate Development of Warner Chilcott plc (WCRX), a “global specialty pharmaceutical company” headquartered in Dublin, Ireland. [read post]